News

Trials Show Organic Tool Could Mitigate the Impact of HLB

Mountain Valley MD Holdings Inc. (MVMD) recently reported positive results from ongoing citrus field trials in Brazil for its Agrarius™ signaling technology.

Brazil citrus trials show higher yields with Agrarius™ technology

Mountain Valley MD Holdings Inc. (MVMD) has reported updated results from ongoing citrus field trials in Brazil evaluating its Agrarius signaling technology.

Global talent key to CEO's growth plans for MVMD

'The idea of hiring someone local is also a limiter on language and skill,' says company president

MVMD’s game-changing technology for higher yields and greener farms

Through its groundbreaking product, Agrarius, MVMD is addressing challenges in crop disease management, sustainable farming, and the future of biotechnology in agriculture.

MVMD CEO Interview on Agrarius™ Technology

MVMD CEO Interview's on Agrarius™ technology and the opportunity for revolutionizing the agriculture industry

Request to patent in Chile, technology that looks promising to improve aquaculture production by 145%

Soluvec 1%, which is 2,500 times more soluble than standard ivermectin, improves its potential efficacy and its ability to be absorbed as an antiparasitic in fish.

Mountain Valley MD Accelerates Business Expansion

Mountain Valley MD Holdings Inc. has made significant progress in advancing the commercialization of its three core business areas

Anti-parasitic coated feed due to go on the market within weeks

A Canadian biotech company that has applied its proprietary technology to the antiparasitic drug ivermectin to develop a more soluble medicine, Soluvec 1%

Agrarius™ - Helping Farmers Feed the World

Canada Bangla Agro Commences Soluvec Fish Feed Production

Canadian Bangladesh Agro Commences Soluvec Fish Feed Production

Premium Fish Feed Launching in Bangladesh

Today's Parent talks with MVMD CEO about Sleep Prioritization

MVMD President & CEO, Dennis Hancock, discusses why it's important to prioritize sleep and how to set up the most effective routines.

What Clinical Trial Experts Think Will Happen With AI In 2024

Heading into 2024, as with any annual flip of the calendar, we anticipate there will be topics of conversation that will fade away, persist, and develop — in the clinical trials industry as in life.

Sleepless in the City: How Mountain Valley MD is Pioneering Natural Sleep Solutions for a More Productive Workforce

Sleepless in the City: How Mountain Valley MD is Pioneering Natural Sleep Solutions for a More Productive Workforce

Mountain Valley MD to welcome new finance chief in January

MVMD to welcome new finance chief in January

MVMD's patented Soluvec™ pharmacokinetic characterization study published

Read the physical and pharmacokinetic characterization of MVMD's Soluvec™, a novel, solvent-free aqueous ivermectin formulation

MVMD & Agrarius: The Partnership That’s Revolutionizing Agriculture

Read about Agrarius™, the worlds first all-organic plant signaling technology

Authority Magazine Interview with MVMD CEO

Read MVMD President & CEO, Dennis Hancock's, interview with Authority Magazine

Watch: 2022 MVMD Annual General Meeting

Watch MVMD's 2022 Annual General Meeting recap video, reviewing all of MVMD's business lanes in depth

MVMD kicks off commercial sales of Agrarius

MVMD starts commercial sales of Agrarius™, the newest innovation of organic plant signaling technology

Watch: MVMD CEO Comments on Agrarius Technology

MVMD President & CEO, Dennis Hancock, comments on Agrarius technology and discusses current progress

MVMD Completes Pre-clinical Pharmacokinetic Study for Soluvec™

Read the results for MVMD's Soluvec™ pre-clinical pharmacokinetic study.